✦ LIBER ✦

The Influence of Physician Densities and Patient Characteristics on the Decision to Treat Prostate Cancer Patients with Varying Clinical Benefit

✍ Scribed by Aneja, S.; Makarov, D.; Gross, C.; Roberts, K.; Yu, J.B.

Book ID: 122835765
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.871

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival benefit of definitive therapy i

Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis

✍ Gandaglia, Giorgio; Sun, Maxine; Trinh, Quoc-Dien; Becker, Andreas; Schiffmann, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

637 Survival benefit of radical prostate

637 Survival benefit of radical prostatectomy in patients with clinically advanced prostate cancer: Estimations of the number needed to treat based on competing-risks analysis

✍ Gandaglia, G.; Sun, M.; Trudeau, V.; Roghmann, F.; Meskawi, M.; Becker, A.; Perr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

129No influence of TURP on the outcome o

129No influence of TURP on the outcome of patients treated with radiotherapy and early orchiectomy for clinical stage C prostate cancer

✍ Wiegel, T.; Tepel, J.; Franke, H.D. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 105 KB

The influence of clinical assessment (in

The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cancer

✍ Decoster, Lore; Kenis, Cindy; Van Puyvelde, Katrien; Flamaing, Johan; Conings, G 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 223 KB

PD12-11 SURVIVAL BENEFIT OF RADICAL PROS

PD12-11 SURVIVAL BENEFIT OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY ADVANCED PROSTATE CANCER: ESTIMATIONS OF THE NUMBER NEEDED TO TREAT BASED ON COMPETING-RISKS ANALYSIS

✍ Gandaglia, Giorgio; Sun, Maxine; Hu, Jim; Schiffmann, Jonas; Becker, Andreas; Po 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

176 NUMBER NEEDED TO TREAT AND RISK BENE

176 NUMBER NEEDED TO TREAT AND RISK BENEFIT ANALYSIS OF DENOSUMAB VERSUS ZOLEDRONIC ACID IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES

✍ Xie, Jipan; Diener, Melissa; Wu, Eric; Sorg, Rachael; Yu, Andrew; Namjoshi, Madh 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB